PTO Issues Broad Guidelines for Gene Patents, Allows Patenting of ESTs | GenomeWeb

NEW YORK, Jan 5 - The U.S. Patent and Trade Office reaffirmed its broad policy of patenting genes Friday, issuing a set of guidelines that respond to a variety of concerns about the patentability of genetic information.

“DNA compounds having naturally occurring sequences are eligible for patenting when isolated from their natural state and purified and when the application meets the statutory criteria for patentability,” the guidelines said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.